Genpharmasec Ltd

NSE: ADIRASA · BSE: 531592 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹1.09
Market cap: ₹60.36 Cr
Revenue (annual): ₹139.9 Cr
Net profit (annual): ₹1.60 Cr
P/E (TTM): -495.4×Sector 47.3×
Promoter holding: 29.98%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 3 Financial Results 3 Board Meeting Date 3 Other Announcement 2 New Order Win 1 Management Change 1 Fund Raise 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 16:03 IST BSE

Financial Results

Genpharmasec Q1 FY27 Results: Net Loss of ₹0.2 Cr

Genpharmasec Ltd reported revenue from operations of ₹49.7 Cr (+314.2% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.

Key figure: Net loss ₹0.2 Cr

Open full results → Read the filing ↗

21 May 2026 17:27 IST BSE

Financial Results

Genpharmasec Q4 FY26 Results: Turns Profitable, Net Profit ₹1.4 Cr

Genpharmasec Ltd reported revenue from operations of ₹55.4 Cr (+295.7% YoY) and net profit of ₹1.4 Cr for Q4 FY26.

Key figure: Net profit ₹1.4 Cr

Open full results → Read the filing ↗

21 May 2026 17:26 IST BSE

Financial Results

Genpharmasec Financial Results

Genpharmasec Limited reported its audited standalone and consolidated financial results for fiscal year 2026. The board also re-appointed M/s. Abhishek M Agrawal & Co. as internal auditors.

Read the filing ↗